CBDistillery® Stress Management Study Featured in Peer-Reviewed Cannabis Journal

As leaders of the #CBDMOVEMENT®, CBDistillery® is committed to providing transparent resources and industry-leading research to help consumers make informed decisions about CBD and other hemp-derived products.

The journal Medical Cannabis and Cannabinoids, by Karger Publishers, featured a recent study we conducted in partnership with MoreBetter, Ltd. which compared our Broad Spectrum and Isolate CBD oils to find their effectiveness at stress management.

The study concluded that participants found both products were efficacious and helped them manage day-to-day stress, with effectiveness ratings higher in the broad spectrum product while the isolate CBD tincture offered a preferable taste.

“We are encouraged by the results of the study. It yet again provides hard evidence that ingestible CBD products can significantly improve the quality of someone’s life and could be a strong natural alternative to traditional treatments in certain cases,” said Chase Terwilliger, CEO of Balanced Health Botanicals (BHB), the parent company of CBDistillery.

John Harloe, General Counsel of BHB who has his Ph.D. in Pharmacology & Toxicology, added, “We are 70 years behind on cannabis research due to decades of misguided Federal policy, so the importance and necessity of all forms of cannabis research cannot be understated. These data represent yet another big step forward in understanding the efficacy, safety, and therapeutic potential of cannabis.”

You can read the journal article here.